Your search returned 24 studies. (Get alerts for new studies):
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- A Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
4 Locations available
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Conditions: Breast Cancer
1 Location available
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
37 Locations available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Pos
Conditions: Her2 Negative Breast Cancer Patients
21 Locations available
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
6 Locations available
- Efficacy and Safety of Chloroquine in Combination With Taxane or Taxane-like Chemotherapy in the Treatment of Advanced or Metastatic Breast Cancer Pat
Conditions: Breast Neoplasms - Breast Cancer
1 Location available
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Conditions: HER2 Amplified Breast Cancer - Metastatic or Advanced Breast Cancer
3 Locations available
- Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
Conditions: Advanced or Metastatic Breast Cancer
5 Locations available
- AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
Conditions: Breast Cancer - Metastatic Breast Cancer - HER-2 Positive Breast Cancer - ER Positive Breast Cancer
1 Location available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients With Locally Advanced or Metastatic Stage
Conditions: Locally Advanced Breast Cancer - Metastatic (Stage IV) Breast Cancer - Stage III-IV Breast Cancer or Inflammatory
1 Location available
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
9 Locations available
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
3 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
|